Abstract
tuberculous (2%), sarcoid (2%) andunknown (20%).Cytologywas positive in 22%of all patients tested and 94%were exudates. Procedural success was 100% with no major complications or mortality. Mean total fluid drained was 553ml with extended catheter drainage used for a mean duration of 2 (range 1–4) days. Significant recurrences were noted in 8%. Definitive therapy was chemotherapy in 29% and creation of a surgical pericardial window in 11% of patients. Conclusion:CT fluoroscopy is a safe and effective strategy for pericardiocentesis with low complication rates. It is particularly useful in high risk patients with coagulopathy and when available should be considered a first line technique in all patients that are hemodynamically stable. doi:10.1016/j.hlc.2009.05.095
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
